Loading...

Home
ETF
RIGL

RIGL

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

RIGL News

Rigel Partners with Arvinas and Pfizer for Breast Cancer Treatment

22h agostocktwits

Arvinas and Rigel Reach Licensing Agreement for Breast Cancer Therapy

1d agoseekingalpha

Rigel Pharmaceuticals Q1 2026 Earnings Call Insights

May 06 2026seekingalpha

Rigel Pharmaceuticals Reports Q1 Earnings Decline

May 06 2026NASDAQ.COM

Rigel Pharmaceuticals Q1 Earnings Miss Expectations

May 05 2026seekingalpha

Rigel Pharmaceuticals to Report Q1 2026 Financial Results

Apr 28 2026PRnewswire

Eli Lilly Ends Collaboration with Rigel on Ocadusertib

Apr 21 2026seekingalpha

Rigel Pharmaceuticals Grants Restricted Stock Units to Employees

Apr 07 2026PRnewswire

CytomX Therapeutics Stock Surges 44.23% Following Positive Phase 1 Data

Mar 16 2026Fool

CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data

Mar 16 2026NASDAQ.COM

CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data

Mar 16 2026Yahoo Finance

Rigel Pharmaceuticals Shares Hit Four-Month Low Amid Revenue Decline Projections

Mar 04 2026seekingalpha

Rigel Pharmaceuticals Reports Strong 2025 Financial Results

Mar 03 2026PRnewswire

Rigel Pharmaceuticals Q4 Earnings Exceed Expectations

Mar 03 2026seekingalpha

Rigel Pharmaceuticals to Announce Q4 Earnings on March 3

Mar 02 2026seekingalpha

Wall Street's First Trading Day of March Outlook

Mar 01 2026CNBC